Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The cellular membranes of antigen-presenting cells (APCs), such as dendritic cells, macrophages, and B cells, serve as the primary interface for the initiation of the adaptive immune response. These membranes are complex lipid bilayers that house essential proteins including Major Histocompatibility Complex (MHC) molecules, co-stimulatory ligands, and various pattern recognition receptors (PRRs) that facilitate the detection of pathogens and the activation of T cells (Source: Frontiers in Immunology, 2021). In pharmacological contexts, these membranes are often the site of action for vaccine adjuvants like Alum, which interact with the plasma membrane to stimulate the NALP3 inflammasome and enhance antigen uptake (Source: Nature Immunology, 2008). Furthermore, the emerging field of biomimetic nanotechnology utilizes these membranes to coat synthetic nanoparticles, allowing them to evade the immune system or target specific tissues by mimicking the natural surface properties of immune cells (Source: Nature Nanotechnology, 2017). While critical for immune function and drug delivery, the term refers to a broad cellular compartment rather than a specific molecular target, making it a structural entity in drug development.
Membrane-mediated adjuvant activity, biomimetic targeting, membrane fusion for nucleic acid delivery, and receptor-mediated endocytosis.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cellular membranes of antigen-presenting and immune cells.